| |
 |
|
Class Information
Number: 530/387.3
Name: Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof > Proteins, i.e., more than 100 amino acid residues > Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc. > Globulins > Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed > Chimeric, mutated, or recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rfv, immunoglobulin fusion protein, etc.)
Description: Subject matter involving an antibody or antibody fragment altered with respect to its amino acid sequence; with respect to its composition of heavy and light chains or immunoglobulin domains; or with respect to its glycosylation, as compared with that found in nature; or involving an antibody or antibody fragment fused to a nonimmunoglobulin amino acid sequence.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7625561 |
Diabody which specifically binds Streptococcus surface antigen I/II and methods of use thereof |
Dec. 1, 2009 |
| 7625560 |
Humanized antibodies that recognize beta amyloid peptide |
Dec. 1, 2009 |
| 7622113 |
Monoclonal antibodies that bind or neutralize dengue virus |
Nov. 24, 2009 |
| 7622112 |
Anti-SARS monoclonal antibodies |
Nov. 24, 2009 |
| 7619071 |
Antibodies that bind interleukin-17 receptor homologue |
Nov. 17, 2009 |
| 7619070 |
Humanized antibodies to interferon alpha receptor-1 (IFNAR-1) |
Nov. 17, 2009 |
| 7618633 |
Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses |
Nov. 17, 2009 |
| 7615217 |
Artificial proteins with reduced immunogenicity |
Nov. 10, 2009 |
| 7615215 |
Anti-human VEGF receptor Flt-1 monoclonal antibody |
Nov. 10, 2009 |
| 7615214 |
Anti-human VEGF receptor Flt-1 monoclonal antibody |
Nov. 10, 2009 |
| 7615213 |
Antibodies against human interleukin-13 and pharmaceutical compositions thereof |
Nov. 10, 2009 |
| 7612181 |
Dual variable domain immunoglobulin and uses thereof |
Nov. 3, 2009 |
| 7612180 |
Humanized L243 antibodies |
Nov. 3, 2009 |
| 7612179 |
antibodies binding to a C-terminal fragment of apoliopoprotein E |
Nov. 3, 2009 |
| 7612170 |
Co-stimulatory polypeptides |
Nov. 3, 2009 |
| 7611708 |
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
Nov. 3, 2009 |
| 7611707 |
Glycoprotein VI antibodies and methods thereof |
Nov. 3, 2009 |
| 7611702 |
TNF-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy |
Nov. 3, 2009 |
| 7608696 |
IBC-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
Oct. 27, 2009 |
| 7608695 |
Substance with antithrombotic activity and method for detecting glycokallidin |
Oct. 27, 2009 |
| 7608694 |
Antibody molecules having specificity for human IL-1.beta. |
Oct. 27, 2009 |
| 7608693 |
High affinity human antibodies to human IL-4 receptor |
Oct. 27, 2009 |
| 7608692 |
Exendins and exendin agonists modified with albumin |
Oct. 27, 2009 |
| 7608268 |
Ferritin fusion proteins for use in vaccines and other applications |
Oct. 27, 2009 |
| 7605237 |
High affinity human antibodies to human IL-4 receptor |
Oct. 20, 2009 |
| 7605233 |
Tumour necrosis factor binding ligands |
Oct. 20, 2009 |
| 7605229 |
PRO87299 polypeptides |
Oct. 20, 2009 |
| 7604800 |
Anti-PSGL-1 antibodies |
Oct. 20, 2009 |
| 7601818 |
Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors |
Oct. 13, 2009 |
| 7601814 |
Reducing the immunogenicity of fusion proteins |
Oct. 13, 2009 |
| 7598353 |
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
Oct. 6, 2009 |
| 7597889 |
Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
Oct. 6, 2009 |
| 7597886 |
Tumor necrosis factor-gamma |
Oct. 6, 2009 |
| 7595051 |
Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies |
Sep. 29, 2009 |
| 7595047 |
Compositions and methods for promoting or inhibiting angiogenesis |
Sep. 29, 2009 |
| 7592429 |
Sclerostin-binding antibody |
Sep. 22, 2009 |
| 7592427 |
Antibodies to IL-21 receptor |
Sep. 22, 2009 |
| 7592426 |
Anti-mesothelin antibodies |
Sep. 22, 2009 |
| 7592313 |
Method of stimulating proliferation of regulatory T cells in a diabetic mammal |
Sep. 22, 2009 |
| 7592007 |
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
Sep. 22, 2009 |
| 7592006 |
Composition comprising the LO-CD2a antibody |
Sep. 22, 2009 |
| 7589182 |
Anti-sulfotyrosine antibodies |
Sep. 15, 2009 |
| 7589181 |
Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their use |
Sep. 15, 2009 |
| 7589180 |
Specific binding proteins and uses thereof |
Sep. 15, 2009 |
| 7589179 |
IL-7 variants with reduced immunogenicity |
Sep. 15, 2009 |
| 7589175 |
Human OX2 receptors |
Sep. 15, 2009 |
| 7585953 |
Antibodies specific for TAT285-1 |
Sep. 8, 2009 |
| 7585952 |
Human mini-antibody cytotoxic for tumor cells which express the ErbB2 receptor |
Sep. 8, 2009 |
| 7585943 |
Compositions and methods for fusion protein separation |
Sep. 8, 2009 |
| 7585840 |
Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
Sep. 8, 2009 |
|
|
|
